Phase II study of weekly gemcitabine in advanced non-small cell lung cancer.

Halme, M

Phase II study of weekly gemcitabine in advanced non-small cell lung cancer. [electronic resource] - Respiratory medicine Aug 1997 - 423-6 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

0954-6111

10.1016/s0954-6111(97)90257-2 doi


Adult
Aged
Antimetabolites, Antineoplastic--adverse effects
Carcinoma, Non-Small-Cell Lung--drug therapy
Deoxycytidine--adverse effects
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Survival Rate
Treatment Outcome
Gemcitabine